An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
Four young physician-researchers at P&S have received research funding from the Louis V. Gerstner Jr. Scholar Program.
Two Treatments for RP Closer to Clinical Trials
Personalized stem cell transplants for age-related macular degeneration may reach clinical trials soon.
Overall, 17% of children…
Lab Study Shows an Improved Form of Vitamin A May Help